Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Journal of Clinical Psychopharmacology|October 5, 2018
Eleven Years of Clozapine Experience in Autism Spectrum Disorder: Efficacy and ToleranceMaud Rothärmel, Fanny Szymoniak, Charlotte Pollet, et al.
Synapse (New York, N.Y.)|September 5, 2006
Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivoRajesh Narendran, Mark Slifstein, Olivier Guillin, et al.
Journal of Alzheimer'S Disease : JAD|November 29, 2013
Dementia in middle-aged patients with schizophreniaGaël Nicolas, Laurène Beherec, Didier Hannequin, et al.
Schizophrenia Research|July 27, 2019
Specificity and sensitivity of the Self-assessment of Negative Symptoms (SNS) in patients with schizophreniaSonia Dollfus, Camille Delouche, Cécile Hervochon, et al.
L'Encephale|May 28, 2023
Opening the black box of hospitalizations in French high-secure psychiatric forensic unitsThomas Fovet, Chloé Saint-Dizier, Marielle Wathelet, et al.
Drug Testing and Analysis|July 2, 2019
Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disordersThomas Duflot, Marianne Vasse, Jennifer Guillerme, et al.
Molecular Imaging and Biology|May 3, 2007
In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390Jesper Ekelund, Mark Slifstein, Raj Narendran, et al.
Pageof 5